GSK plc Logo

GSK plc

Develops specialty medicines and vaccines to prevent and treat a range of global diseases.

GSK | NYSE

Overview

Corporate Details

ISIN(s):
GB0009252882
LEI:
Country:
United States of America
Address:
79 NEW OXFORD STREET, 0 LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company researches, develops, and manufactures a portfolio of specialty medicines and vaccines. Its primary R&D is concentrated in four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Leveraging advancements in immunology and human genetics, GSK aims to deliver transformative treatments. The company is also committed to expanding global health access by making its products more affordable and available through strategic partnerships and responsible pricing programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:10
Foreign Filer Report
6-K - GSK plc (0001131399) (Filer)
English 62.0 KB

Automate Your Workflow. Get a real-time feed of all GSK plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GSK plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GSK plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Canopy Growth Corp Logo
Produces diverse cannabis products for medical and recreational markets globally.
United States of America CGC
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAPRICOR THERAPEUTICS, INC. Logo
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
United States of America CAPR
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
Caribou Biosciences, Inc. Logo
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America CRBU
Carisma Therapeutics Inc. Logo
Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.
United States of America CARM
Cartesian Therapeutics, Inc. Logo
Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.
United States of America RNAC
CASI Pharmaceuticals, Inc. Logo
Develops and commercializes drugs for oncology, transplant, and autoimmune disease.
United States of America CASI
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing oral drug simufilam for CNS disorders like TSC-related epilepsy.
United States of America SAVA
CATALYST PHARMACEUTICALS, INC. Logo
Advancing therapies for rare neuromuscular and neurological diseases like LEMS.
United States of America CPRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.